China investigates France outline&evolution injectable synthetic gel

According to the state Food and Drug Administration Website news, marked as "France Procytech S.A.S" production of "outline&evolution injectable synthetic gel" Three batches of products of sodium chloride content, acrylamide monomer residue and ultraviolet absorption spectrometry, and other items do not meet the standard requirements, The state Food and Drug Administration has asked to conduct investigations. Recently, the state Food and Drug Administration received the report of the Guangdong Provincial Food and Drug Administration, reflected in the supervision and inspection and testing found that marked as "French Procytech S.a.s" production of "outline&evolution injectable synthetic gel" (Registration number: National food drug Surveillance Equipment ( Enter) 2005 No. 3460818 (more)) "Three batches of products (batch number: U21196, U20190, U20187) of sodium chloride content, acrylamide monomer residue and ultraviolet absorption spectrometry and other items do not meet the standard requirements. The National Bureau has commissioned the Guangdong, Shanghai, Hainan Province (city) Food and Drug Administration of the jurisdiction of the relevant medical devices operating enterprises suspected of illegal violations of the investigation. According to the Hainan Province Food and Drug Administration report, Hainan Provincial bureau has ordered the product's general agent Dongfangwei Medical Equipment Co., Ltd. recalls all "Outline&evolution injectable synthetic gel" products.